Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Vasomotor Symptoms (VMS)
Interventions: DRUG: oral capsule of Q-122
Sponsor: Que Oncology